1.Preparation and Quality Control of Compound Fluorouracil Gel
Genshan DONG ; Jiaofeng WANG ; Ping TANG
China Pharmacy 2005;0(22):-
OBJECTIVE:To prepare compound fluorouracil gel and to establish a method for its quality control.METHODS:Carbomer-940 was used as base material to prepare the compound fluorouracil gel.The content determination of fluorouracil and hydrocortisone was performed by RP-HPLC,and the stability and irritability of this preparation were investigated as well.RESULTS:The gel prepared was well-distributed,with property,identification and tests all in conformity with the description of China Pharmacopeia(2005 edition).The good linear ranges of fluorouracil and hydrocortisone were 0.06~ 0.14mg? mL-1(r=0.999 8)and 0.006~ 0.014mg? mL-1(r=0.999 9),respectively,and the average recovery rates of whi-ch were 100.70%(RSD=0.51%)and 99.88%(RSD=0.83%),respectively.The gel remained stable after storing for 6mo at room temperature away from light,and there was no significant difference in irritability as compared with blank base material.CONCLUSION:The preparation technique of compound fluorouracil gel is simple and practicable,and its quality is reliable.
2.Effectiveness and safety of the side-branch balloon pre-imbedding technique on coronary bifurcation lesions in elderly patients
Yong QIAO ; Gaoliang YAN ; Dong WANG ; Jing WANG ; Wenjie KONG ; Genshan MA ; Chengchun TANG
Chinese Journal of Geriatrics 2016;35(2):151-155
Objective To study the effectiveness and safety of the side-branch (SB) balloon preimbedding technique on coronary bifurcation lesions (CBLs) in elderly patients.Methods A retrospective analysis was conducted on 111 elderly patients with CBLs in our hospital from January 2011 to January 2013,of whom 59 patients received SB balloon pre-imbedding and 52 patients received SB wire protection.The immediate blood flow of the side-branch after treatment,the performance of the stent,and major adverse cardiovascular events (MACE) during hospitalization,6 and 12 months after treatment,and coronary angiography 6 months after treatment were compared between the two groups.Results There were no statistical differences between the two groups in clinical characteristics,lesion distribution,length and diameter of MB or SB,bifurcation angle,length and number of main branch(MB) stenting,or MACE during hospitalization and 6 months after treatment (each P>0.05).There was no statistical difference in immediate postoperative angiography between patients with thrombolysis in myocardial infarction (TIMI) grade 3,coronary stenosis more than 25% in the MB (P>0.05).The percentages of patients with coronary stenosis more than 50 % in SB and patients who needed SB stenting were lower in the balloon pre-imbedding group than in the wire protectiongroup[8.5% (5/59) vs.23.1% (12/52),42.4% (25/59) vs.61.5% (32/52),each P<0.05].After 6 months of treatment,there was no statistical difference in coronary angiography in TIMI grade 3 of MB and coronary stenosis more than 25% in MB between the two groups (P>0.05)Also,the percentage of patients with TIMI grade 3 in SB was higher in the balloon pre-imbedding group than in the wire protection group (37/41 vs.24/34,P<0.05);the percentage of patients with coronary stenosis more than 50% in SB was lower in the balloon pre-imbedding group than in the wire protection group (3/41 vs.8/34,P<0.05);and the degree of stenosis,the late lumen loss and the incidence of stem restenosis in SB were lower in the balloon pre-imbedding group than in the wire protection group (P<0.01).The incidence of MACE 12 months after PCI was lower in the balloon pre-imbedding group than in the wire protection group (7/59 vs.14/52,P<0.05).The pre-balloon imbedding group had a lower cost than the wire protection group,but with no statistical significance [(55 113±968) RMB vs.(61 023±1 311) RMB,P>0.05].Conclusions SB balloon preimbedding is safe for the treatment of CBLs in elderly patients,and its effectiveness in both short-and long-term is better than that of wire protection.
3.Effects of serum cystatin C level on the occurrence and its long-term prognosis of contrast agent-induced acute kidney injury after coronary intervention in elderly patients
Gaoliang YAN ; Dong WANG ; Zhongpu CHEN ; Xiaodong PAN ; Zulong SHENG ; Pengfei ZUO ; Qianxing ZHOU ; Chunju YUAN ; Chengchun TANG ; Genshan MA
Chinese Journal of Geriatrics 2021;40(1):62-66
Objective:To investigate the effect of serum cystatin C level on the occurrence and its long-term prognosis of contrast agent-induced acute kidney injury(CI-AKI)after percutaneous coronary intervention(PCI)in elderly patients.Methods:A total of 848 elderly patients(≥60 years)undergoing PCI in our department between Mar 2015 and Dec 2017 were enrolled in a prospective cohort.The CI-AKI was defined as the increase of serum creatinine ≥44.2 μmol/L within 48-72 h after using iodine contrast agent or more than 25 % higher than base level within 48-72 h after PCI.A receiver operating characteristic curve was used to analyze the optimal cut-off value of Cystatin C for predicting CI-AKI after PCI.Patients were divided into 2 groups based on the optimal cut-off value of Cystatin C: the high Cystatin C group(Cystatin C ≥1.3 mg/L, n=178)and the control group(Cystatin C<1.3 mg/L, n=670). The differences in the incidence of CI-AKI after PCI and major adverse cardiac events(MACE)at 1 year follow-up were compared between the two groups.The Cox regression model was further used to analyze the predictors of the long-term prognosis after PCI.Results:Of 848 patients receiving PCI, the incidence of CI-AKI was 9.4%.The incidence of MACE at 1 year after PCI was higher in the high Cystatin C group than in the control group(15.7% vs.9.3%, χ2=6.524, P=0.011). Cox regression analysis confirmed that the high baseline level of Cystatin C was the most independent predictive factor for MACE at 1 year of follow-up( HR=16.244, P<0.001). Conclusions:The high baseline level of Cystatin C(≥1.3 mg/L)is an independent risk factor for CI-AKI and is also the most important predictor for the occurrence of long-term MACE in elderly patients undergoing PCI.
4.Impact of plasma homocysteinemia on contrast-induced nephropathy after percutaneous coronary intervention in patients with coronary syndrome.
Gaoliang YAN ; Wenjie KONG ; Dong WANG ; Yong QIAO ; Xiang SHA ; Tianyu CHENG ; Hairong ZHANG ; Jiantong HOU ; Chengchun TANG ; Genshan MA
Chinese Journal of Cardiology 2016;44(1):32-37
OBJECTIVETo explore the impact of plasma homocysteinemia(Hcy) on contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients.
METHODSConsecutive 684 ACS patients undergoing first PCI in our department between January 2013 and December 2014 were prospectively enrolled.Patients were divided into 2 groups according to the pre-procedural plasma Hcy level: high-Hcy group (Hcy≥10 μmol/L, n=404) and control group (Hcy<10 μmol/L, n=280). The CIN was defined as serum creatinine ≥ 44.2 μmol/L or 25% increase compared to baseline within 48-72 h after PCI.The baseline clinical data and the ratio of CIN were compared between the 2 groups.Multivariate logistic regression analysis was used to define the independent risk factors for CIN.
RESULTSCIN occurred in 133(19.4%) out of 684 enrolled patients, and the incidence of CIN was significantly higher in high Hcy group than in the control group (22.0%(89/404)vs. 15.7%(44/280), P=0.040). After adjusting the confounding factors, including age, acute myocardial infarction, co-morbidities(hypertension, diabetes mellitus, and old myocardial infarction), laboratory examination (level of cystatin C and uric acid), glomerular filtration rate, left ventricular ejection fraction, angiographic and procedural characteristics (3 diseased vessels, multiple stent implantation), treatment at admission (spironolactone, digoxin), multivariate logistic regression analysis showed that high Hcy was independently associated with the development of CIN (OR=1.70, 95%CI 1.60-2.64, P=0.021).
CONCLUSIONElevated Hcy prior PCI is an independent risk factor of CIN in ACS patients undergoing first PCI.
Acute Coronary Syndrome ; Diabetes Mellitus ; Glomerular Filtration Rate ; Humans ; Hyperhomocysteinemia ; Incidence ; Kidney Diseases ; Myocardial Infarction ; Percutaneous Coronary Intervention ; Risk Factors ; Ventricular Function, Left